<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49">
 <label>49.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ball</surname>
    <given-names>JP</given-names>
   </name>
   <name>
    <surname>Springer</surname>
    <given-names>MJ</given-names>
   </name>
   <name>
    <surname>Ni</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Finger-Baker</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hahn</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Intranasal delivery of a bivalent norovirus vaccine formulated in an 
   <italic>in situ</italic> gelling dry powder
  </article-title>. 
  <source>PLoS ONE.</source> (
  <year>2017</year>) 
  <volume>12</volume>:
  <fpage>e0177310</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0177310</pub-id>
  <?supplied-pmid 28545100?>
  <pub-id pub-id-type="pmid">28545100</pub-id>
 </mixed-citation>
</ref>
